Impakter
  • PARTNERS
  • ABOUT US
    • Our Story
    • Team
    • Write for Impakter
    • Contact Us
    • Privacy Policy
No Result
View All Result
  • Climate
  • Business
  • Energy
  • Tech
  • Politics
  • Health
  • Food & Agriculture
  • Society
  • Climate
  • Business
  • Energy
  • Tech
  • Politics
  • Health
  • Food & Agriculture
  • Society
No Result
View All Result
Impakter
No Result
View All Result

The Case for and Against America’s Role in the WHO

One Health is a key approach to "Make America Healthy Again" — and the WHO with CDC can make it happen

byRichard Seifman - Former World Bank Senior Health Advisor and U.S. Senior Foreign Service OfficerandDr. Bruce Kaplan - Epidemiologist formerly at the CDC/EIS and USDA-FSIS Office of Public Health and Science & Co-Founder of the One Health Initiative
January 27, 2025
in Editors' Picks, Health
Trump WHO

On January 20, 2025, U.S. President Donald J. Trump signed an Executive Order “WITHDRAWING THE UNITED STATES FROM THE WORLD HEALTH ORGANIZATION (WHO),” which currently has 194 members. The reaction has been varied and swift by politicians, scientists, and advocacy groups, with reasonably predictable opinions. In truth, while there are valid arguments both for and against such an action, what is required is an objective weighing the situation, health needs and review of the institutional mandate, and possible areas of reform. Such an approach would lead to a reasoned judgment on conditioning U.S. continuing engagement and financing, all with the underlying goal to protect and save American lives and others.

The World Health Organization’s Past and Present

The Kaiser Family Foundation (KFF) is respected as an independent source for health policy research, polling, and news source. It described the WHO and the U.S. past relationship with key points as follows as follows:

  • The U.S. government (U.S.) has been actively engaged with WHO throughout its history, providing financial and technical support as well as participating in its governance structure.
  • Historically, the U.S. has historically been one of the largest funders of WHO. U.S. contributions have ranged between $163 million and $816 million annually over the last decade.
  • Over the last several years WHO has overseen negotiation processes to update an existing agreement known as the International Health Regulations (IHR), and to establish a potential new “pandemic agreement”.
  • In 2024, WHO launched its first ever “investment round,” seeking to mobilize an additional $7 billion from existing and new donors to support its operations through 2028. As of the end of 2024, the organization reported it received $3.8 billion in additional donor pledges, amounting to 53% of its fundraising goal.

President Trump cited the “mismanagement of the COVID-19 pandemic and other global health crises” and the “disproportionate payments compared to other countries’ dues.”

The graph below shows the top 10 contributors to WHO for the biennium 2022-23 were the United States of America, Germany, Bill & Belinda Gates Foundation, Gavi, European Commission, UK, Canada, Rotary International, Japan, and France.

U.S. and WHO Cooperation

Probably the most important U.S. Government counterpart to a core of WHO’s responsibility is the Centers for Disease Control and Prevention (CDC). It is well-considered worldwide by many domestic and international public health leaders as a critical partnership, and collaborator with WHO.

For example, the CDC and WHO have joined in the adoption of a One Health approach, which is the interface of human, animal, plant, and ecosystem health. This allows for much more powerful synergistic force multipliers well beyond conventional sectoral siloed approaches to achieve desired prevention, preparation, and response to infectious diseases. We need to achieve institutionalizing the critical One Health model to prevent life-threatening disaster(s) in future.

This is best possible through an international organization concerned with health. Such a broadened approach should be the aim and result of continued and active U.S. membership in reforming WHO to make it better serve its mission, both for the U.S. and for all countries.

Some Reasons Not to Stay

There are other instances, but most recent was WHO’s handling/mishandling throughout the COVID-19 pandemic. It is widely recognized that it began in Wuhan, China, but the cause, whether from an animal or laboratory leak, has not been resolved. One reason is that the People’s Republic of China (PRC), as a major WHO power, has not fully cooperated with the investigation, creating mistrust.

Further, the WHO has suffered from its governance structure with constrained independence to act, reliance on voluntary and inflexible funding which hampers reliability and sustainability of its operations, as well as self-imposed bureaucratic limitations that have slowed more effective action(s) to deal with basic global health security challenges.

Any assessment of WHO’s performance would be remiss if it did not address “political” issues, which should not be swept aside by those in favor of the U.S. staying. Already mentioned is how the PRC thwarted in-depth investigation of the origins of COVID-19. Another example concerns the October 2023 Israeli-Hamas war, during which WHO reports were concentrated on the Gaza numbers of dead and wounded but essentially silent on Hamas’s use of Gaza hospitals as locations for terrorists.

According to Richard Goldberg, a senior adviser at the Foundation for Defense of Democracies and former Trump National Security Council official, “Several international organizations operating in Gaza likely had direct knowledge of Hamas using hospitals as terror headquarters and only publicly protested Israel’s attempt to clear the terrorists. The Red Cross, UNRWA, and World Health Organization — they were all collaborators.” Whether accurate or not, such allegations create a basis for WHO antagonists to mistrust the organization.

Some Reasons to Stay

As mentioned, this organization has undergone some reforms, such as a strengthened International Health Regulations. Going further, according to Bloomberg Business Week and other publications, to cope with the next pandemic, there are measures that fall within WHO’s purview, which include better emerging pathogen control; better tracking of pathogens and variants; greater vaccine availability with more companies; quicker resolution of patent issues, and improved measures in logistics, coordination, and planning.

A stronger and more independent WHO, with its expert staff and access to scientific and other professional and business experts in relation to health problems, infectious diseases, pandemic prevention and control, is well positioned to do what is needed. But only if it is given the wherewithal to do so.

What Trump Can Do if He Chooses

President Trump is known as a tough and effective negotiator. These skills can be extremely valuable when applied to the right objective. If he so decides, he can change the course of global public (and clinical research) health history by pursuing ways to advance U.S. and international public health. He can use these talents to improve WHO (“Make it Great Again”).

In the short time after being elected before being in office, the President significantly helped bring about a ceasefire and hostage release in the Israeli negotiations with the Hamas terrorists. He can bring to bear his skill and have a lasting positive effect — he can do it!


Editor’s Note: The opinions expressed here by the authors are their own, not those of Impakter.com — In the Cover Photo: World Health Organization logo. Cover Photo Credit: Wikimedia Commons.

Share
WhatsApp LinkedIn X Facebook
Tags: CDChealthOne HealthTrumpUnited StatesUSWHOWorld Health Organization
Previous Post

Tech Industry To Invest in Green Energy as AI Demand Surges

Next Post

Tesla and BMW Sue the EU Over Imposed China-Made EV Tariffs

Richard Seifman - Former World Bank Senior Health Advisor and U.S. Senior Foreign Service Officer

Richard Seifman - Former World Bank Senior Health Advisor and U.S. Senior Foreign Service Officer

Richard Seifman is a former World Bank Senior Health Advisor and U.S. Senior Foreign Service Officer, and Honorary Diplomate of the American Veterinary One Health Sociery (AVOHS). He has a Juris Doctor degree from Columbia University Law School and is a Senior Columnist at Impakter.

Dr. Bruce Kaplan - Epidemiologist formerly at the CDC/EIS and USDA-FSIS Office of Public Health and Science & Co-Founder of the One Health Initiative

Dr. Bruce Kaplan - Epidemiologist formerly at the CDC/EIS and USDA-FSIS Office of Public Health and Science & Co-Founder of the One Health Initiative

Bruce Kaplan, DVM, Dipl. AVES (Hon.), CDC/EIS63 is the co-founder of the One Health Initiative. He has held positions in public health with the Centers for Disease Control and Prevention (CDC) as an epidemiologist and the USDA's Office of Public Health and Science in Washington, D.C. He also served as the USDA-FSIS public affairs specialist in California for 14 western states. Dr. Kaplan earned his Doctor of Veterinary Medicine Degree (D.V.M.) from Auburn University in 1963. Listed in Who’s Who in America65th Ed. 2011 and 66th Ed. 2012, his awards include the AVMA's Practitioner Research Award, the USDA's Group Honor Award for Excellence, an Honorary Diploma from the American Veterinary Epidemiology Society (AVES), the Karl F. MeyerJames H. Steele Gold Headed Cane Award (2012) and an American Association of Public Health Physicians Presidential Award for Meritorious Service (2013). He formerly worked as an Editor/Writer/Public Affairs consultant. Until October 2001, he was editing/writing the Ask a Veterinarian column in the St. Petersburg Times. Dr. Kaplan currently devotes his time to promoting One Health.

Next Post
ESG news regarding Tesla and BMW sue EU, Water companies greenwashing in England, Swedish Energy Agency fund bio-CCS project, Shift4Good raise 200 million euros

Tesla and BMW Sue the EU Over Imposed China-Made EV Tariffs

Related News

Business professional photographed for an interview

Can the Creative Industries Grow Sustainably? Joe Blackman on Events, Business and Climate

August 29, 2026
Satellite image of Benin City in Nigeria.

A Visionary Approach to Implementing Sustainability Solutions

August 28, 2026

Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com

Registered Office Address

Klimado GmbH
Niddastrasse 63,

60329, Frankfurt am Main, Germany


IMPAKTER is a Klimado GmbH website

Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).


Office Hours - Monday to Friday

9.30am - 5.00pm CEST


Email

stories [at] impakter.com

By Audience

  • TECH
    • Start-up
    • AI & MACHINE LEARNING
    • Green Tech
  • ENVIRONMENT
    • Biodiversity
    • Energy
    • Circular Economy
    • Climate Change
  • INDUSTRY NEWS
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
    • Editorial Series

ESG/Finance Daily

  • ESG News
  • Business

About Us

  • Team
  • Partners
  • Write for Impakter
  • Contact Us
  • Privacy Policy

© 2026 IMPAKTER. All rights reserved.

No Result
View All Result
  • Climate
  • Business
  • Energy
  • Tech
  • Politics
  • Health
  • Food & Agriculture
  • Society

© 2026 IMPAKTER. All rights reserved.